High Tide (HITI) highlights 229-store cannabis chain ahead of Q3 webcast
Rhea-AI Filing Summary
High Tide Inc. (HITI) filed a report stating it will release financial and operational results for its third fiscal quarter ended July 31, 2026 after markets close on September 14, 2026. The results will be posted on SEDAR+, EDGAR and the company’s website.
A webcast to discuss these results with CEO Raj Grover and CFO Mayank Mahajan is scheduled for 11:30 Eastern Time on September 15, 2026, with pre-registration encouraged and a replay available three hours after the live event. High Tide highlights its cannabis retail footprint, including 229 Canna Cabana locations and its German medical cannabis distribution business, Remexian Pharma GmbH.
Positive
- None.
Negative
- None.
Key Figures
Quarter end date: July 31, 2026
Results release date: September 14, 2026
Webcast time: 11:30 Eastern Time on September 15, 2026
+5 more
8 metrics
Quarter end date
July 31, 2026
End of High Tide’s third fiscal quarter 2026
Results release date
September 14, 2026
Date financial and operational results will be released after market close
Webcast time
11:30 Eastern Time on September 15, 2026
Scheduled webcast to discuss third fiscal quarter 2026 results
Canna Cabana locations in Canada
229 locations
Domestic Canadian cannabis retail locations operated by Canna Cabana
International Canna Cabana locations
1 location
International bricks-and-mortar Canna Cabana presence
Canadian cannabis retail market share
12%
Canna Cabana’s share of the Canadian cannabis retail market
German medical cannabis market share
14%
Remexian Pharma GmbH share of German medical cannabis market
Countries Remexian can import from
22 countries
Number of countries from which Remexian is licensed to import medical cannabis
Key Terms
foreign private issuer, forward-looking statements, medical cannabis, annual information form, +1 more
5 terms
foreign private issuer regulatory
"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
forward-looking statements regulatory
"CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This press release may contain"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
medical cannabis medical
"German medical cannabis market, built for the purpose of importation and wholesale"
Medical cannabis is the use of cannabis plant extracts or compounds such as THC and CBD as prescribed or recommended to treat symptoms or medical conditions. Think of it as a plant-based medicine that can relieve pain, nausea, muscle spasms or other symptoms where conventional drugs may not work; for investors it matters because legal status, clinical evidence, supply rules and insurance coverage determine market size, licensing value and revenue potential.
annual information form regulatory
"risk factors discussed under the heading "Non-Exhaustive List of Risk Factors" in Schedule A to our current annual information form"
A company's annual information form is a comprehensive regulatory filing that lays out its business description, key assets, risks, legal matters and other background details shareholders need to understand the company’s operations. Think of it as a detailed owner’s manual or dossier that supplements financial statements, helping investors do deeper homework on how the business works and what could affect its future performance.
Regulation Services Provider regulatory
"Neither the TSXV nor its Regulation Services Provider accepts responsibility"
A regulation services provider is a firm that helps companies meet legal and market rules by preparing, filing and distributing required reports, disclosures and licenses to regulators and exchanges. Think of them as a combination of a guidebook and filing clerk that keeps a company on the right side of the law and visible to the market. Investors care because reliable regulatory work reduces legal risk, prevents trading disruptions and ensures timely access to material information that affects share value.
FAQ
When will High Tide Inc. (HITI) report its third fiscal quarter 2026 results?
High Tide will release its third fiscal quarter 2026 financial and operational results for the quarter ended July 31, 2026 after financial markets close on Monday, September 14, 2026. The results will be available on SEDAR+, EDGAR and the company’s website.
When is the HITI earnings webcast for Q3 2026 and who will present?
The webcast is scheduled for 11:30 Eastern Time on Tuesday, September 15, 2026. It will feature Raj Grover, Founder and CEO, and Mayank Mahajan, CFO, who will discuss the company’s financial results and the remainder of the fiscal year.
How can investors access High Tide’s Q3 2026 earnings webcast?
Investors can access the webcast via https://app.webinar.net/4WqyjMOJnKb. Participants are encouraged to pre-register, and a replay will be available at the same link about three hours after the live webcast concludes.
What phone numbers can investors use to ask questions during the HITI earnings event?
Participants may ask questions via a call-in line. The North American toll-free number is 1-888-510-2154, and the international toll-free number for Germany is 498005889782, as provided in the disclosure.
What is High Tide Inc.’s current cannabis retail footprint?
High Tide’s Canna Cabana chain is described as the largest cannabis retail chain in Canada, with 229 domestic and 1 international location. The Canadian bricks-and-mortar network spans five provinces and holds a 12% market share in Canada.
What is High Tide’s position in the German medical cannabis market?
High Tide’s subsidiary Remexian Pharma GmbH is described as a leading German pharmaceutical company with a 14% share of the German medical cannabis market, licensed to import medical cannabis products from 22 countries, including Canada.
AI-generated analysis. How Rhea-AI works. Not financial advice.
